Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000213378 | SCV000277073 | likely benign | Hereditary cancer-predisposing syndrome | 2015-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001705223 | SCV000530299 | likely benign | not provided | 2019-04-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 15122587) |
Labcorp Genetics |
RCV004567620 | SCV000647687 | benign | Familial adenomatous polyposis 1 | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000213378 | SCV000687108 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-22 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000213378 | SCV004014997 | likely benign | Hereditary cancer-predisposing syndrome | 2023-05-25 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001705223 | SCV004220510 | benign | not provided | 2023-01-25 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003998004 | SCV004843489 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-07-22 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004567620 | SCV005083911 | benign | Familial adenomatous polyposis 1 | 2024-04-08 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |